The published Phase 3 mean weight reduction for retatrutide (28.3%) is nearly double the figure for semaglutide in STEP-1 (14.9%) over comparable trial durations
A reduction of 1.6% in A1C levels, the measurement of average blood glucose over the course of three months, is significant for people with Type 2 diabetes, who tend to have higher blood sugar levels and need to manage those levels to avoid secondary problems, such as heart disease, kidney disease or vision loss, according to the Centers for Disease Control and Prevention
These microbes interact directly with your bodys systems, including hormone production
The muscle question is more alarming still
Metabolic surgery, also referred to as bariatric surgery, has a profound effect on metabolism that greatly accelerates weight loss
Research has shown that average weight loss over one year is 14.9% of total body weight with semaglutide, with more than one-third of patients losing greater than 20%